Anne-Gaëlle Fournial

Title: The Innovative Contributions of Anne-Gaëlle Fournial

Introduction

Anne-Gaëlle Fournial is a notable inventor based in La Madeleine, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent related to cyclodextrin complexes.

Latest Patents

Fournial holds a patent for a pharmaceutical composition comprising cyclodextrin complexes of anethole trithione or its derivatives. This composition includes anethole trithione or a derivative thereof, sulfobutyl ether-beta-cyclodextrin, and optionally a co-solvent. The patent specifies that the ratio of sulfobutyl ether-beta-cyclodextrin to the compound of formula (I) ranges from 10 to 400, with a preferred range of 57 to 200. The composition is intended for use as a drug, specifically for the treatment and/or prevention of diseases related to free oxygen radicals. Additionally, it encompasses a kit-of-parts and/or a medical device that includes the composition, as well as a method for solubilizing the compound in an aqueous medium.

Career Highlights

Fournial's career is marked by his dedication to pharmaceutical innovation. His work has led to advancements in drug formulations that can potentially improve treatment outcomes for various medical conditions.

Collaborations

Throughout his career, Fournial has collaborated with notable colleagues, including Nicolas Pineau and El Mustapha Belgsir. These partnerships have contributed to the development and refinement of his innovative ideas.

Conclusion

Anne-Gaëlle Fournial's contributions to the field of pharmaceuticals through his patent demonstrate his commitment to advancing medical science. His work not only highlights the importance of innovation in drug development but also showcases the potential for improved health outcomes through scientific research.